Effect of mid-dose efavirenz concentrations and CYP2B6 genotype on viral suppression in patients on first-line antiretroviral therapy

International Journal of Antimicrobial Agents - Tập 47 - Trang 466-472 - 2016
Catherine Orrell1, Andrzej Bienczak2, Karen Cohen2, David Bangsberg3,4,5, Robin Wood1, Gary Maartens2, Paolo Denti2
1Desmond Tutu HIV Centre, Institute of Infectious Disease and Molecular Medicine and Department of Medicine, University of Cape Town, Cape Town, South Africa
2Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa
3Harvard Medical School, Boston, MA, USA
4Massachusetts General Hospital Center for Global Health, Boston, MA, USA
5Ragon Institute of Massachusetts General Hospital, Boston, MA, USA

Tài liệu tham khảo

Thông tin
Thông tin xuất bản

International Journal of Antimicrobial Agents

Tập 47

466-472

Thông tin tác giả